Academic Summary: This study compared the metabolic and neural effects of D-Allulose and oral semaglutide in diet-induced obese mice. Both substances significantly reduced food intake and body weight in the early stages by activating anorexigenic (leptin-responsive) neurons in the arcuate nucleus of the hypothalamus. However, D-Allulose uniquely inhibited orexigenic (hunger-stimulating, ghrelin-responsive) neurons and utilized a combined vagal afferent and central nervous route. This allowed for persistent weight loss even after the treatment was discontinued, whereas semaglutide-treated subjects experienced a weight rebound. Additionally, both treatments equally elevated grip strength.

Formal AMA Citation: Rakhat Y, Banno S, Zhantleu D, et al. D-Allulose Reduces Weight More Persistently than Oral Semaglutide While Both Equally Elevate Grip Strength in Diet-Induced Obese Mice. Nutrients. 2026;18(4):707 . https://doi.org/10.3390/nu18040707.

#WeightLossScience #GLP1 #Allulose #Metabolism #TheHarmonicNexus #Biology #HealthTech #ObesityResearch #Neurobiology

NARRATOR: Ralph Turchiano

ANALYSIS: Gemini

Medical Disclaimer: This content is for informational purposes only based on animal model research and does not constitute medical advice. Always consult a healthcare professional before beginning any new supplement or medication.

Alchepharma,Ralph Turchiano,citation,research,study,D-Allulose,Oral Semaglutide,Weight Loss Rebound,GLP-1 Receptor Agonist,Rare Sugars,Obesity Treatment 2026,Metabolic Health,Sarcopenic Obesity,Ghrelin Inhibition,Leptin Sensitivity,Arcuate Nucleus,Vagal Afferent Nerve,Diet-Induced Obesity,Anorexigenic Neurons,Orexigenic Neurons,Zero Calorie Sweeteners,Neurobiology of Feeding,Weight Maintenance,Endogenous GLP-1,Gut-Brain Axis,Satiety Hormones